valsartan has been researched along with Cardiovascular Pregnancy Complications in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biswas, PN; Shakir, SW; Wilton, LV | 1 |
Berkane, N; Carlier, P; Heim, N; Mathieu, E; Uzan, S; Verstraete, L | 1 |
Bos-Thompson, MA; Boulot, P; Dechaud, H; Hillaire-Buys, D; Mazurier, E; Morin, D; Muller, F | 1 |
Madelenat, P; Mahieu-Caputo, D; Popovic, I; Roger, N | 1 |
Benachi, A; Daikha-Dahmane, F; Gubler, MC; Laurent, N; Martinovic, J | 1 |
2 review(s) available for valsartan and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
Fetal toxicity of valsartan and possible reversible adverse side effects.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Kidney; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tetrazoles; Ultrasonography; Valine; Valsartan | 2004 |
Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
Topics: Amniotic Fluid; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; beta 2-Microglobulin; Child, Preschool; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan | 2005 |
3 other study(ies) available for valsartan and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Dizziness; Drug Monitoring; England; Female; Headache; Humans; Hypertension; Male; Middle Aged; Nausea; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Product Surveillance, Postmarketing; Tetrazoles; Valine; Valsartan | 2002 |
[Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Renal Insufficiency; Tetrazoles; Valine; Valsartan | 2007 |
Fetal toxic effects and angiotensin-II-receptor antagonists.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Hypertension; Losartan; Pregnancy; Pregnancy Complications, Cardiovascular; Tetrazoles; Valine; Valsartan | 2001 |